Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Sally S. Lee, M.D.
Internal Medicine · STRATFORD, CT · NPI 1447221189
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 451 | 44 |
| Atorvastatin Calcium | Atorvastatin Calcium | 339 | 74 |
| Sertraline Hcl | Sertraline Hcl | 296 | 47 |
| Famotidine | Famotidine | 248 | 40 |
| Amlodipine Besylate | Amlodipine Besylate | 236 | 43 |
| Metoprolol Succinate | Metoprolol Succinate | 224 | 46 |
| Levothyroxine Sodium | Levothyroxine Sodium | 218 | 47 |
| Mirtazapine | Mirtazapine | 209 | 55 |
| Gabapentin | Gabapentin | 189 | 40 |
| Furosemide | Furosemide | 177 | 43 |
| Trazodone Hcl | Trazodone Hcl | 162 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 147 | 37 |
| Metformin Hcl | Metformin Hcl | 126 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 112 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 103 | 29 |
| Baclofen | Baclofen | 102 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 98 | 21 |
| Bumetanide | Bumetanide | 96 | 28 |
| Potassium Chloride | Potassium Chloride | 94 | 17 |
| Pentoxifylline | Pentoxifylline | 93 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 89 | 18 |
| Oxycodone Hcl | Oxycodone Hcl | 84 | 22 |
| Lorazepam | Lorazepam | 83 | 27 |
| Divalproex Sodium | Divalproex Sodium | 82 | 12 |
| Torsemide | Torsemide | 81 | 15 |
| Spironolactone | Spironolactone | 79 | 26 |
| Omeprazole | Omeprazole | 77 | 28 |
| Myrbetriq | Mirabegron | 76 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 72 | suppressed |
| Lisinopril | Lisinopril | 71 | 21 |
| Levetiracetam | Levetiracetam | 62 | 17 |
| Pantoprazole Sodium | Pantoprazole Sodium | 58 | 24 |
| Latanoprost | Latanoprost | 56 | 14 |
| Olanzapine | Olanzapine | 55 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 53 | 13 |
| Jardiance | Empagliflozin | 53 | suppressed |
| Losartan Potassium | Losartan Potassium | 52 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | 14 |
| Alendronate Sodium | Alendronate Sodium | 48 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 48 | 20 |
| Atenolol | Atenolol | 47 | 11 |
| Carvedilol | Carvedilol | 47 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 47 | 19 |
| Clonidine Hcl | Clonidine Hcl | 46 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 46 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 44 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 42 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 40 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 39 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 38 | 17 |
| Prednisone | Prednisone | 38 | 23 |
| Simvastatin | Simvastatin | 38 | suppressed |
| Xarelto | Rivaroxaban | 36 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Lamotrigine | Lamotrigine | 35 | suppressed |
| Memantine Hcl | Memantine Hcl | 35 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 33 | 15 |
| Diltiazem 24hr Er | Diltiazem Hcl | 33 | suppressed |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 33 | suppressed |
| Allopurinol | Allopurinol | 32 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Risperidone | Risperidone | 32 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 27 | suppressed |
| Clotrimazole | Clotrimazole | 27 | 18 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 27 | 27 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 18 |
| Trulicity | Dulaglutide | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Scopolamine | Scopolamine | 24 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 24 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Carbamazepine | Carbamazepine | 22 | suppressed |
| Cephalexin | Cephalexin | 22 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 22 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 13 |
| Clobetasol Propionate | Clobetasol Propionate | 21 | suppressed |
| Finasteride | Finasteride | 21 | suppressed |
| Ketoconazole | Ketoconazole | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 20 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 20 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 20 | suppressed |
| Silodosin | Silodosin | 20 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 20 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 14 |
| Hydrocortisone | Hydrocortisone | 19 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Fentanyl | Fentanyl | 18 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 18 | suppressed |
| Nyamyc | Nystatin | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | 15 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Amantadine | Amantadine Hcl | 16 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Cefdinir | Cefdinir | 15 | 14 |
| Clonazepam | Clonazepam | 15 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Oxycontin | Oxycodone Hcl | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Securesafe Pen Needle | Pen Needle, Diabetic, Safety | 14 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 14 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 12 | suppressed |
| Ingrezza | Valbenazine Tosylate | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Azithromycin | Azithromycin | 11 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Multaq | Dronedarone Hcl | 11 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error